U.S. markets open in 2 hours 21 minutes
  • S&P Futures

    4,248.75
    +3.00 (+0.07%)
     
  • Dow Futures

    34,466.00
    +4.00 (+0.01%)
     
  • Nasdaq Futures

    14,042.00
    +47.75 (+0.34%)
     
  • Russell 2000 Futures

    2,330.90
    +0.40 (+0.02%)
     
  • Crude Oil

    71.37
    +0.46 (+0.65%)
     
  • Gold

    1,856.40
    -23.20 (-1.23%)
     
  • Silver

    27.83
    -0.31 (-1.10%)
     
  • EUR/USD

    1.2123
    +0.0016 (+0.13%)
     
  • 10-Yr Bond

    1.4620
    0.0000 (0.00%)
     
  • Vix

    15.93
    -0.17 (-1.06%)
     
  • GBP/USD

    1.4106
    -0.0011 (-0.08%)
     
  • USD/JPY

    109.6780
    +0.0430 (+0.04%)
     
  • BTC-USD

    39,354.78
    +3,360.45 (+9.34%)
     
  • CMC Crypto 200

    979.65
    +37.84 (+4.02%)
     
  • FTSE 100

    7,162.58
    +28.52 (+0.40%)
     
  • Nikkei 225

    29,161.80
    +213.07 (+0.74%)
     

Intercept to Present at the 2021 RBC Capital Markets Global Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, May 12, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief Executive Officer of Intercept, will present at the 2021 RBC Capital Markets Global Healthcare Conference on Wednesday, May 19, 2021 at 4:50 p.m. ET.

A live webcast of the event will be available on the investor page of Intercept’s website at http://ir.interceptpharma.com. An audio archive of the webcast will also be available on Intercept’s website for approximately two weeks.

About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.

CONTACT

For more information about Intercept, please contact:

Investor inquiries: investors@interceptpharma.com

Media inquiries: media@interceptpharma.com

Source: Intercept Pharmaceuticals, Inc.